BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 26244818)

  • 1. Nanoparticle-mediated drug delivery for treating melanoma.
    Mundra V; Li W; Mahato RI
    Nanomedicine (Lond); 2015; 10(16):2613-33. PubMed ID: 26244818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine as a potent strategy in melanoma tumor microenvironment.
    Pautu V; Leonetti D; Lepeltier E; Clere N; Passirani C
    Pharmacol Res; 2017 Dec; 126():31-53. PubMed ID: 28223185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upcoming strategies for the treatment of metastatic melanoma.
    Spagnolo F; Queirolo P
    Arch Dermatol Res; 2012 Apr; 304(3):177-84. PubMed ID: 22350184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapeutical strategies in the treatment of metastatic disease.
    Julia F; Thomas L; Dalle S
    Dermatol Ther; 2012; 25(5):452-7. PubMed ID: 23046024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual Encapsulated Dacarbazine and Zinc Phthalocyanine Polymeric Nanoparticle for Photodynamic Therapy of Melanoma.
    do Reis SRR; Helal-Neto E; da Silva de Barros AO; Pinto SR; Portilho FL; de Oliveira Siqueira LB; Alencar LMR; Dahoumane SA; Alexis F; Ricci-Junior E; Santos-Oliveira R
    Pharm Res; 2021 Feb; 38(2):335-346. PubMed ID: 33604784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in nanomedicine for melanoma treatment.
    Tang JQ; Hou XY; Yang CS; Li YX; Xin Y; Guo WW; Wei ZP; Liu YQ; Jiang G
    Int J Cancer; 2017 Aug; 141(4):646-653. PubMed ID: 28340496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in targeted therapy for unresectable melanoma: new drugs and combinations.
    Hao M; Song F; Du X; Wang G; Yang Y; Chen K; Yang J
    Cancer Lett; 2015 Apr; 359(1):1-8. PubMed ID: 25578781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New drug targets in metastatic melanoma.
    Homet B; Ribas A
    J Pathol; 2014 Jan; 232(2):134-41. PubMed ID: 24027077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic Therapy for Metastatic Melanoma Treatment: A Review.
    Naidoo C; Kruger CA; Abrahamse H
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818791795. PubMed ID: 30099929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The discovery of vemurafenib for the treatment of BRAF-mutated metastatic melanoma.
    Kim A; Cohen MS
    Expert Opin Drug Discov; 2016 Sep; 11(9):907-16. PubMed ID: 27327499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging targeted therapies for melanoma.
    Johnson DB; Pollack MH; Sosman JA
    Expert Opin Emerg Drugs; 2016 Jun; 21(2):195-207. PubMed ID: 27148822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination of photodynamic therapy and chemotherapy displays a differential cytotoxic effect on human metastatic melanoma cells.
    Biteghe FN; Davids LM
    J Photochem Photobiol B; 2017 Jan; 166():18-27. PubMed ID: 27852006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Nanoparticles in Delivery of Nucleic Acids for Melanoma Treatment.
    Obeid MA; Aljabali AAA; Rezigue M; Amawi H; Alyamani H; Abdeljaber SN; Ferro VA
    Methods Mol Biol; 2021; 2265():591-620. PubMed ID: 33704742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drugs in melanoma: it's a whole new world.
    Eggermont AM; Robert C
    Eur J Cancer; 2011 Sep; 47(14):2150-7. PubMed ID: 21802280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DR5 mAb-conjugated, DTIC-loaded immuno-nanoparticles effectively and specifically kill malignant melanoma cells in vivo.
    Ding B; Zhang W; Wu X; Wang J; Xie C; Huang X; Zhan S; Zheng Y; Huang Y; Xu N; Ding X; Gao S
    Oncotarget; 2016 Aug; 7(35):57160-57170. PubMed ID: 27494835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dacarbazine in combination with bevacizumab for the treatment of unresectable/metastatic melanoma: a phase II study.
    Ferrucci PF; Minchella I; Mosconi M; Gandini S; Verrecchia F; Cocorocchio E; Passoni C; Pari C; Testori A; Coco P; Munzone E
    Melanoma Res; 2015 Jun; 25(3):239-45. PubMed ID: 25746039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma.
    Wang AX; Qi XY
    IUBMB Life; 2013 Sep; 65(9):748-58. PubMed ID: 23893853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting metastatic melanoma.
    Flaherty KT
    Annu Rev Med; 2012; 63():171-83. PubMed ID: 22034865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in Polymeric Nanosystems for Treating Cutaneous Melanoma and Its Metastasis.
    Chou YP; Lin YK; Chen CH; Fang JY
    Curr Pharm Des; 2017; 23(35):5301-5314. PubMed ID: 28699537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the MEK inhibitor trametinib in the treatment of metastatic melanoma.
    King JW; Nathan PD
    Future Oncol; 2014; 10(9):1559-70. PubMed ID: 25145427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.